A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
Titel:
A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
Auteur:
Dijkgraaf, E.M. Santegoets, S.J.A.M. Reyners, A.K.L. Goedemans, R. Wouters, M.C.A. Kenter, G.G. van Erkel, A.R. van Poelgeest, M.I.E. Nijman, H.W. van der Hoeven, J.J.M. Welters, M.J.P. van der Burg, S.H. Kroep, J.R.